Login

Journal Image
Current Cancer Drug Targets
ISSN (Print): 1568-0096
ISSN (Online): 1873-5576
VOLUME: 5
ISSUE: 3
DOI: 10.2174/1568009053765816      Price:  $58









Modulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer

img
Author(s): Lucy L. Seville, Nita Shah, Andrew D. Westwell and Weng C. Chan
Pages 159-170 (12)
Abstract:
Cell proliferation is regulated by the cell cycle, and in order to divide the cell must enter a mitotic state. Prior to mitosis the cell is required to pass through a number of checkpoints, including the critical G1/S restriction point governed by the successive phosphorylation of the retinoblastoma protein, pRb. The various proteins and regulatory factors governing pRb phosphorylation have been a major focus of study in recent years, given the central importance of G1/S transition deregulation in cancer development. This review summarises the molecular biology around the G1/S transition, focussing on the critical roles of the transcription factor family E2F and the cyclin-dependent kinase (CDK) and cyclin families involved in E2F release from pRb. Interestingly, E2F release from pRb is associated with cell proliferation; however, above a certain threshold E2F has the potential to trigger apoptosis. The review focuses on the following topics: (i) how E2F and other substrates bind to pRb at the molecular level; (ii) mechanisms by which pRb function is modulated within the cell; (iii) mechanisms that inhibit or enhance cell proliferation via the pRb/E2F pathway; (iv) how E2F can potentiate apoptotic pathways; and (v) what controls whether E2F mediates cell proliferation or apoptosis. The case for the development of agents that perturb pRb:E2F interactions will be made, as a strategy to further inform the molecular biology around this important target and as a therapeutic strategy against cancer.
Keywords:
cell proliferation, checkpoints, phosphorylation, apoptosis, cdks, ef family, transcription factor, transactivation domain, pocket-protein binding, rb gene
Affiliation:
School of Pharmacy, The Centre for Biomolecular Sciences, University of Nottingham, UniversityPark, Nottingham NG7 2RD, UK.